Literature DB >> 9973376

IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells.

T Aarvak1, M Chabaud, P Miossec, J B Natvig.   

Abstract

IL-17 is defined as a proinflammatory cytokine and produced by activated CD4+ T cells. In rheumatoid arthritis synovial tissue, high levels of IL-17 contribute to IL-6 production by synoviocytes. The present study was performed to see whether Th cells that produce IL-17 are associated with the Th1, Th2, or Th0 subset. Thirty-three CD4+, alphabeta+ T cell clones were developed from synovial membranes and synovial fluid of rheumatoid arthritis patients. Thirteen clones were defined as Th1 since they produced IFN-gamma but not IL-4, and four clones were defined as Th0 type that produced both IL-4 and IFN-gamma. Sixteen clones were defined as Th2 since they produced high levels of IL-4 and/or IL-10 but not IFN-gamma. IL-17 was measured in a bioassay, where IL-6 production from synoviocytes was a measurement for IL-17 activity in the presence and absence of blocking anti-IL-17 mAb. Three Th1 clones and two Th0 clones produced IL-17. In contrast, none of the sixteen Th2 clones analyzed produced IL-17. In addition, six Th2 clones were further cultured in conditions that induced a switch to Th1 type. Induction of this Th1 phenotype also led to production of IL-17 in two of these clones. The results demonstrate that some cells of the Th1/Th0 phenotype produce IL-17 but not cells of the Th2 phenotype. Thus, IL-17 may define a new subset of T cells, and IL-17 production appears to be a mechanism for Th1/Th0 cells, the most frequent Th subtype present in the rheumatoid synovium, to contribute to the local inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973376

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  97 in total

Review 1.  Immunological basis of Chlamydia induced reactive arthritis.

Authors:  J S Gaston
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

Review 2.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

3.  Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression.

Authors:  Guillaume Page; Arne Sattler; Sabine Kersten; Andreas Thiel; Andreas Radbruch; Pierre Miossec
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 4.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 5.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

6.  Th17 cells can provide B cell help in autoantibody induced arthritis.

Authors:  Cynthia L Hickman-Brecks; Jennifer L Racz; Debra M Meyer; Timothy P LaBranche; Paul M Allen
Journal:  J Autoimmun       Date:  2010-11-13       Impact factor: 7.094

7.  Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?

Authors:  Javad Ghaffari; Ali Reza Rafiei; Abolghasem Ajami; Mohammadreza Mahdavi; Bahareh Hoshiar
Journal:  Caspian J Intern Med       Date:  2011

Review 8.  Th17 cells: effector T cells with inflammatory properties.

Authors:  Thomas Korn; Mohamed Oukka; Vijay Kuchroo; Estelle Bettelli
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

Review 9.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

10.  Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.

Authors:  R L Van Bezooijen; L Van Der Wee-Pals; S E Papapoulos; C W G M Löwik
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.